Lumexa Imaging Holdings (LMRI) Stock Overview
Owns and operates diagnostic imaging centres in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
LMRI Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Lumexa Imaging Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.51 |
| 52 Week High | US$19.45 |
| 52 Week Low | US$6.45 |
| Beta | 0 |
| 1 Month Change | -24.90% |
| 3 Month Change | -51.61% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -59.45% |
Recent News & Updates
Recent updates
Outpatient Imaging Shift And AI Adoption Will Reshape Long Term Prospects
Catalysts About Lumexa Imaging Holdings Lumexa Imaging Holdings operates outpatient medical imaging centers that provide advanced and routine diagnostic imaging services across multiple states in partnership with health systems and referring physicians. What are the underlying business or industry changes driving this perspective?
Aging Demographics And Outpatient Shift Will Drive Stronger Imaging Demand Over Time
Catalysts About Lumexa Imaging Holdings Lumexa Imaging Holdings operates outpatient imaging centers that provide advanced and routine diagnostic imaging services across the United States. What are the underlying business or industry changes driving this perspective?
Advanced Imaging And JV Dependence Will Pressure Margins Yet Gradual Operational Gains Will Emerge
Catalysts About Lumexa Imaging Holdings Lumexa Imaging Holdings operates outpatient diagnostic imaging centers that provide advanced and routine imaging services across the United States. What are the underlying business or industry changes driving this perspective?Lumexa Imaging: Clearer Growth Path Ahead
Summary Lumexa Imaging remains a Buy, with Q4 2025 results clarifying the medium-term growth and margin trajectory. Advanced imaging volumes and mix are rising, driving superior unit economics and margin expansion; FastScan rollout is a key throughput catalyst. De novo center openings reached a record, with rapid breakeven timelines supporting compounding organic growth and future margin upside. Balance sheet deleveraging and disciplined capital allocation enhance LMRI’s ability to fund growth, with valuation offering attractive upside. Read the full article on Seeking AlphaShareholder Returns
| LMRI | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -8.1% | -0.3% | 1.2% |
| 1Y | n/a | 11.8% | 27.0% |
Return vs Industry: Insufficient data to determine how LMRI performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how LMRI performed against the US Market.
Price Volatility
| LMRI volatility | |
|---|---|
| LMRI Average Weekly Movement | 14.1% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.9% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: LMRI's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine LMRI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 4,200 | Caitlin Zulla | www.lumexaimaging.com |
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
Lumexa Imaging Holdings, Inc. Fundamentals Summary
| LMRI fundamental statistics | |
|---|---|
| Market cap | US$706.19m |
| Earnings (TTM) | -US$37.70m |
| Revenue (TTM) | US$1.03b |
Is LMRI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LMRI income statement (TTM) | |
|---|---|
| Revenue | US$1.03b |
| Cost of Revenue | US$875.37m |
| Gross Profit | US$155.24m |
| Other Expenses | US$192.94m |
| Earnings | -US$37.70m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.39 |
| Gross Margin | 15.06% |
| Net Profit Margin | -3.66% |
| Debt/Equity Ratio | 138.8% |
How did LMRI perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/02 21:01 |
| End of Day Share Price | 2026/06/02 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Lumexa Imaging Holdings, Inc. is covered by 8 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andrew Mok | Barclays |
| Philip Chickering | Deutsche Bank |
| Brian Tanquilut | Jefferies LLC |